Stocks making the biggest moves midday: Nike, Rent-A-Center, Carnival Cruise


People walk near the entrance to Nike store, May 25, 2022 in Moscow, Russia.

Konstantin Zavrazhin | Getty Images News | Getty Images

Check out the companies making headlines in midday trading.

Nike — Nike shares dropped 12.8% after the sneaker giant said Thursday its inventory was overstocked, up 44% in its latest quarter. As a result it will offer more discounts to clear out the excess merchandise. Other retailers were also dragged down, with Lululemon Athletica and Under Armour losing almost 6% and nearly 5% respectively.

Rent-A-Center — Shares of Rent-A-Center slipped 21.6% after the company slashed its current-quarter earnings guidance, saying that economic conditions have weighed on consumer traffic and payment patterns.

Carnival Cruise — Shares of Carnival Cruise plunged 23.3% after the company forecast a loss for the fourth quarter, saying high fuel prices and inflation will delay its return to profitability. Royal Caribbean and Norwegian Cruise Lines also slipped, falling 13% and 18%, respectively.

Micron — Shares of Micron rose 1.7% after the company reported quarterly earnings that beat Wall Street expectations, even though sales fell. The chipmaker also gave a weaker-than-expected revenue outlook, saying sales are being hit by slowing consumer demand.

Charles River Laboratories — Charles River shares rose 3.6% after Jefferies upgraded the stock to buy from hold, citing the company’s potential in animal studies.

Twitter — Shares of Twitter rose 2.6% after texts between its founder, Jack Dorsey, and Elon Musk were released in court filings. The Tesla CEO is embroiled in a legal battle over his bid to buy the social media company.

Nucor — Shares of steel company Nucor jumped 1.6% after it announced plans to spend $425 million expanding a galvanized steel line at its South Carolina plant.

Amylyx Pharmaceuticals — Shares of the pharmaceutical company dropped 6.8% despite the stock rallying after hours Thursday on news of the Food and Drug Administration approving its controversial Lou Gehrig’s disease drug.

Generac — Shares of Generac gained 2.3% after Cowen initiated coverage of the company with a buy rating. The generator company is a clear industry winner and has value in its solar offering.

— CNBC’s Alex Harring and Michelle Fox contributed reporting.



Source link

Related articles

Kraken’s Guardian Firm Strikes to Purchase a Financial institution in Europe

Key TakeawaysPayward agreed to amass Saldo Financial institution’s Finnish mother or father, securing a path towards an EU banking license.Saldo Financial institution operates throughout 4 European markets, with authorization to develop into the...

Equinor’s Grimsnes discovery provides as much as 50 MMboe close to Oseberg in North Sea

(WO) – Equinor and companions Petoro and TotalEnergies have made an oil and gasoline discovery in exploration nicely 30/8-7 S Grimsnes, close to the Oseberg discipline within the Norwegian North Sea. Preliminary estimates...

Your Android telephone might double as a Steam Deck with this free app that runs PC video games regionally

In short: There are a couple of methods to play PC video games on Android gadgets similar to telephones, however it usually requires streaming them, which is not all the...

Aroon Indicator Methods and Settings

2026.10.14 ...

commerce promotion options

Producers spend money on commerce promotions to extend gross sales, assist distributors, introduce new merchandise, and affect buying habits all through the channel. Nonetheless, as promotional packages develop, managing them by spreadsheets and...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com